Acute	acute	O	O
psychosis	psychosis	O	O
due	due	O	O
to	to	O	O
treatment	treatment	O	O
with	with	O	O
phenytoin	phenytoin	S_chemicals	O
in	in	O	O
a	a	O	O
nonepileptic	nonepileptic	O	S_disease
patient	patient	O	O
.	.	O	O

The	the	O	O
development	development	O	O
of	of	O	O
psychosis	psychosis	O	O
related	related	O	O
to	to	O	O
antiepileptic	antiepileptic	B_chemicals	O
drug	drug	S_chemicals	O
treatment	treatment	O	O
is	is	O	O
usually	usually	O	O
attributed	attributed	O	O
to	to	O	O
the	the	O	O
interaction	interaction	O	O
between	between	O	O
the	the	O	O
epileptic	epileptic	O	O
brain	brain	O	O
substratum	substratum	O	O
and	and	O	O
the	the	O	O
antiepileptic	antiepileptic	B_chemicals	O
drugs	drugs	S_chemicals	O
.	.	O	O

The	the	O	O
case	case	O	O
of	of	O	O
a	a	O	O
nonepileptic	nonepileptic	O	S_disease
patient	patient	O	O
who	who	O	O
developed	developed	O	O
psychosis	psychosis	O	O
following	following	O	O
phenytoin	phenytoin	S_chemicals	O
treatment	treatment	O	O
for	for	O	O
trigeminal	trigeminal	O	B_disease
neuralgia	neuralgia	O	S_disease
is	is	O	O
described	described	O	O
.	.	O	O

This	this	O	O
case	case	O	O
suggests	suggests	O	O
that	that	O	O
the	the	O	O
psychotic	psychotic	O	O
symptoms	symptoms	O	O
that	that	O	O
occur	occur	O	O
following	following	O	O
phenytoin	phenytoin	S_chemicals	O
treatment	treatment	O	O
in	in	O	O
some	some	O	O
epileptic	epileptic	O	O
patients	patients	O	O
may	may	O	O
be	be	O	O
the	the	O	O
direct	direct	O	O
result	result	O	O
of	of	O	O
medication	medication	O	O
,	,	O	O
unrelated	unrelated	O	O
to	to	O	O
seizures	seizures	O	S_disease
.	.	O	O

